Envoy Medical, Inc. (COCH)
NASDAQ: COCH · IEX Real-Time Price · USD
+0.020 (0.66%)
At close: May 23, 2024, 3:59 PM
+0.050 (1.64%)
After-hours: May 23, 2024, 7:52 PM EDT

Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $59.78 million. The enterprise value is $60.19 million.

Market Cap 59.78M
Enterprise Value 60.19M

Important Dates

The last earnings date was Wednesday, May 15, 2024, after market close.

Earnings Date May 15, 2024
Ex-Dividend Date n/a

Share Statistics

Envoy Medical has 19.60 million shares outstanding. The number of shares has increased by 93.63% in one year.

Shares Outstanding 19.60M
Shares Change (YoY) +93.63%
Shares Change (QoQ) +56.14%
Owned by Insiders (%) 63.86%
Owned by Institutions (%) 16.25%
Float 6.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 201.28
Forward PS 136.30
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 202.66
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.11

Current Ratio 1.11
Quick Ratio 0.74
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -638.92

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -235.80%
Return on Capital (ROIC) n/a
Revenue Per Employee $8,735
Profits Per Employee -$692,265
Employee Count 34
Asset Turnover 0.03
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -69.92% in the last 52 weeks. The beta is 1.24, so Envoy Medical's price volatility has been higher than the market average.

Beta (1Y) 1.24
52-Week Price Change -69.92%
50-Day Moving Average 4.43
200-Day Moving Average 4.25
Relative Strength Index (RSI) 38.19
Average Volume (30 Days) 453,743

Short Selling Information

The latest short interest is 22,529, so 0.11% of the outstanding shares have been sold short.

Short Interest 22,529
Short Previous Month 30,527
Short % of Shares Out 0.11%
Short % of Float 0.33%
Short Ratio (days to cover) 0.19

Income Statement

In the last 12 months, Envoy Medical had revenue of $297,000 and -$23.54 million in losses. Loss per share was -$0.21.

Revenue 297,000
Gross Profit -612,000
Operating Income -19.50M
Pretax Income -23.04M
Net Income -23.54M
EBITDA -22.83M
EBIT -23.00M
Loss Per Share -$0.21
Full Income Statement

Balance Sheet

The company has $4.95 million in cash and $5.36 million in debt, giving a net cash position of -$411,000 or -$0.02 per share.

Cash & Cash Equivalents 4.95M
Total Debt 5.36M
Net Cash -411,000
Net Cash Per Share -$0.02
Equity / Book Value -7.41M
Book Value Per Share -0.38
Working Capital 734,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.32 million and capital expenditures -$262,000, giving a free cash flow of -$21.58 million.

Operating Cash Flow -21.32M
Capital Expenditures -262,000
Free Cash Flow -21.58M
FCF Per Share -$1.10
Full Cash Flow Statement


Gross margin is -206.06%, with operating and profit margins of -6,564.98% and -7,924.92%.

Gross Margin -206.06%
Operating Margin -6,564.98%
Pretax Margin -7,756.57%
Profit Margin -7,924.92%
EBITDA Margin -7,688.22%
EBIT Margin -7,744.44%
FCF Margin -7,266.81%

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -93.63%
Shareholder Yield -93.63%
Earnings Yield -39.37%
FCF Yield -36.10%

Analyst Forecast

The average price target for Envoy Medical is $6.00, which is 96.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.00
Price Target Difference 96.72%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Envoy Medical has an Altman Z-Score of -50.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -50.28
Piotroski F-Score 3